Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/1999
10/26/1999US5973155 Process for preparing (-)-trans-N-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-[[3,4-(methylened ioxy)phenoxy]methyl]-piperidine
10/26/1999US5972976 Aminostilbazole derivative and medicine
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972969 Methods of combatting infectious disease using dicationic bis-benzimidazoles
10/26/1999US5972964 Aminomethylindans, -benzofurans and -benzothiophenes
10/26/1999US5972961 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
10/26/1999US5972936 Benzofuran carboxamides and their therapeutic use
10/26/1999US5972925 1-(3-(2-chloro-12h-dibenzo(d,g)(1,3,6)dioxazocin-12-yl)-1-prop yl)-3-piperidinecarboxylic acid, for example; treating neurogenic pain (in which c-fibers play a role) or inflammation such as migraine or diabetic neuropathy
10/26/1999US5972241 Liquid crystal compounds having a chiral fluorinated terminal portion
10/26/1999CA2177576C Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
10/26/1999CA1340801C Optically active pyridonecarboxylic acid derivatives
10/26/1999CA1340798C Disubstituted pyridines
10/21/1999WO1999052903A1 Prodrugs of benzofuranylmethyl carbamate nk1 antagonists
10/21/1999WO1999052902A1 Method for drying anhydrous paroxetine hydrochloride
10/21/1999WO1999052901A1 Paroxetine maleate
10/21/1999WO1999052900A1 Oxidation process using tempo
10/21/1999WO1999052899A1 Oxidation process using periodic acid
10/21/1999WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999WO1999052894A1 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof
10/21/1999WO1999052893A1 N-pyridonyl herbicides
10/21/1999WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999WO1999052888A1 Butenolide derivatives as anti-cancer agents
10/21/1999WO1999052879A1 Acylresorcinol derivatives as selective vitronectin receptor inhibitors
10/21/1999WO1999052878A1 Substituted phenyl pyridazinones
10/21/1999WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application
10/21/1999WO1999052875A1 Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
10/21/1999WO1999052871A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element
10/21/1999WO1999052868A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999WO1999052851A1 Phosphate-mediated cyclization
10/21/1999WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999WO1999046254A3 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis
10/21/1999DE19817265A1 Treating hepatitis B using new or known dihydropyrimidine derivative antiviral agents
10/21/1999CA2328211A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999CA2327931A1 Oxidation process using tempo
10/21/1999CA2327928A1 Phosphate-mediated cyclization
10/21/1999CA2327926A1 Oxidation process using periodic acid
10/21/1999CA2327806A1 Substituted phenyl pyridazinones
10/21/1999CA2327695A1 Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
10/21/1999CA2327450A1 Paroxetine maleate
10/20/1999EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999EP0950656A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
10/20/1999EP0950057A1 3-pyridyl enantiomers and their use as analgesics
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999EP0949921A1 Thrombin inhibitors
10/20/1999CN1232462A Muscarinic antagonists
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232456A PDE IV inhibiting 2-cyanoiminoimidazole derivs.
10/20/1999CN1232453A Ether muscarinic antagonists
10/20/1999CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999CN1232450A 2- and 2,5-substd. phenylketoenols
10/20/1999CN1232399A Inhibitors of cysteine protease
10/20/1999CN1232035A Preparation of beta-methyl carbapenem intermediates
10/20/1999CN1232027A Diresorcinyl-alkoxy-and-aryloxy-s-triazines
10/20/1999CN1232025A Pyrrolidine and piperidine derivatives
10/20/1999CN1045772C Polyazacycloalkanes as dichelants
10/20/1999CN1045770C Method for preparation of 1-biphenylmethyl imidazole derivs.
10/20/1999CN1045768C Angiotension II antagonists compounds, preparing method and use thereof
10/20/1999CN1045767C Pyrazole derivs, processes for preparation thereof and pharmaceutical composition comprising same
10/19/1999US5969184 Amide compounds
10/19/1999US5969151 Pyrazole compounds
10/19/1999US5969139 Inhibitors of herpes simplex virus thymidine kinase
10/19/1999US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999US5969118 Backbone modified oligonucleotide analogs and preparation thereof through radical coupling
10/19/1999US5968977 Ketonitrile derivatives and antibacterial agent and drugs containing the same
10/19/1999US5968971 Endothelin receptor antagonists
10/19/1999US5968968 Analgesic or antiinflammatory agents, also for treatment of strokes, asthma, parkinsonism, psoriasis, irritable bowel syndrome
10/19/1999US5968959 Administering phospholamban inhibitor
10/19/1999US5968958 Non-steroidal antiinflammatory agents or enzyme inhibitors
10/19/1999US5968954 Exhibit selective binding affinity for 5-hydroxytryptamine receptors
10/19/1999US5968942 Inhibitors of hiv protease
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968874 Defoliation or dessication of plants
10/17/1999CA2269262A1 Substituted tricyclics
10/14/1999WO1999051592A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
10/14/1999WO1999051589A1 Substituted piperidines, method for their preparation and their use as pesticides and fungicides
10/14/1999WO1999051582A1 Nitrogenous heterocyclic compounds
10/14/1999WO1999051580A1 Pyrazole inhibitors of cytokine production
10/14/1999WO1999051576A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999WO1999051575A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999WO1999051574A1 Indole derivatives
10/14/1999WO1999051215A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
10/14/1999WO1999045011A8 Glycine transport inhibitors
10/14/1999WO1999032447A3 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
10/14/1999CA2327397A1 Indole derivatives
10/14/1999CA2327360A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
10/14/1999CA2327359A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999CA2327303A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999CA2327185A1 Pyrazole inhibitors of cytokine production
10/13/1999EP0949251A1 Diresorcinyltriazines as sunscreen agents
10/13/1999EP0948963A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
10/13/1999EP0948498A1 Sulfonamide compounds having 5-ht receptor activity
10/13/1999EP0948497A2 Substituted pyrimidine compounds and their use
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948489A1 Piperazine compounds as inhibitors of mmp or tnf
10/13/1999EP0948483A1 Farnesyl transferase inhibitors
10/13/1999EP0948327A1 Antidiabetic agents
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0579618B1 Pyridine- and imidazole-derived agents for cardiovascular diseases
10/13/1999CN1231663A Arthropodicidal and fungicidal cyclic amides
1 ... 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 ... 694